Beiley Biofund
Taipeibeileybiofund.com
Overview
Beiley Biofund is a venture capital firm dedicated to advancing life sciences by partnering with innovators to develop breakthrough therapies and technologies that address unmet medical needs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Libo Pharma Corp. | Jul 2025 | Series C | Co-investor |
| VerImmune | Sep 2024 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
